Wave Life Sciences Sets Terms for IPO
Wave Life Sciences has filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO). The company expects to price its 5 million shares in the…
All Work
Chris Lange
SEC Adopts Rules to Permit Crowdfunding Securities
The U.S. Securities and Exchange Commission (SEC) announced that it has adopted final rules to permit companies to offer and sell securities through crowdfunding. The SEC also voted to propose amendments to existing Securities…
What to Look for in Sprint Earnings
Sprint is expected to report its third-quarter financial results before the markets open on Tuesday.
UTAC Prepares for IPO in the US
UTAC Holdings has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
What to Expect From Tesla Earnings
Tesla Motors is scheduled to report its third-quarter financial results after the markets close on Tuesday.
October’s ISM Manufacturing Not Exactly on Fire
October marks the third consecutive month that the ISM manufacturing reading flirted with contraction.
How Analysts View Pure Storage After Its Quiet Period
The quiet period for Pure Storage has now ended, and underwriters and analysts alike can now issue calls on the stock.
Equity Bancshares Gears Up for IPO With New Pricing Terms
Equity Bancshares expects to price about 1.8 million Class A shares in a range of $22 to $24 in an IPO valued up to more than $49 million.
Axsome Therapeutics Sets Terms for IPO
Axsome Therapeutics expects to price more than 4 million shares in the range of $11 to $13 in an IPO valued up to more than $63 million.
BlackBerry Completes Good Acquisition
Monday morning before the markets opened, BlackBerry announced the completion of its acquisition of Good Technology, and investors appeared respond positively.
Ellipse Technologies Prepares for IPO
The IPO for Ellipse Technologies, a medical technology company focused on revolutionizing orthopedic surgery, is valued up to $75 million.
The 10 Most Important Earnings for the Week Ahead
For the most part, and in conjunction with the Fed deferring to raise rates, the overall market sentiment this earnings season has been fairly positive, with most companies meeting or beating their estimates.
4 Key FDA Decisions Expected in November and December
24/7 Wall St. has collected several big FDA decisions coming up in the month of November.
6 BioPharma Movers That Cannot Be Ignored
Last week, a few biotech companies made absolutely massive runs, and some had serious falls.
5 Companies That Destroyed Shareholders This Past Week
24/7 Wall St. has highlighted a few companies that missed their earnings, contrary to the trend, when they reported this past week.
Medical Tourism Expected to Triple by 2019
Medical tourism has become increasingly popular in recent years as we see the globalization of modern medicine take off, as well as the continued improvement in health care systems within developing nations.
Voyager Therapeutics Sets Terms for IPO
Voyager Therapeutics intends to offer roughly 4.7 million shares within the range of $15 to $17 apiece in an IPO valued up to more than $91 million.
Seagate Builds Momentum With Earnings
Seagate Technology released mixed fiscal first-quarter financial results before the markets opened on Friday.
Is Mylan’s Topline Growth Enough for Investors?
Mylan reported better-than-expected third-quarter financial results before the markets opened on Friday.
AbbVie Soars on Solid Earnings and Guidance
AbbVie reported better-than-expected third-quarter financial results before the markets opened on Friday.